Back to search

Article

Alpha-1 Antitrypsin Overexpressing Mesenchymal Stem/Stromal Cells Reverses Type 1 Diabetes via Promoting Treg Function and CD8 <sup>+</sup> T cell exhaustion

2025-04-21

Abstract excerpt

<h4>ABSTRACT</h4> Mesenchymal stem/stromal cell (MSC) therapy holds great promise as both a therapeutic option and as a biofactory, as cells produce therapeutic proteins to augment their efficacy in disease treatment. This study investigates the therapeutic effects and the mechanistic insights of alpha-1 antitrypsin overexpressing MSCs (AAT-MSCs) in diabetes prevention and treatment. A single infusion of AAT-MSCs...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
12693e02-1017-5a60-be17-fac17162147d
DOI
10.1101/2025.04.19.649667
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alpha-1 Antitrypsin Overexpressing Mesenchymal Stem/Stromal Cells Reverses Type 1 Diabetes via Promoting Treg Function and CD8 <sup>+</sup> T cell exhaustionDOI 10.1101/2025.04.19.649667
Select a neighboring publication to make it the new centre.